1. Home
  2. NUS vs ABEO Comparison

NUS vs ABEO Comparison

Compare NUS & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nu Skin Enterprises Inc.

NUS

Nu Skin Enterprises Inc.

HOLD

Current Price

$7.15

Market Cap

347.0M

Sector

Health Care

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$4.49

Market Cap

280.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUS
ABEO
Founded
1984
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
347.0M
280.2M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
NUS
ABEO
Price
$7.15
$4.49
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$18.75
AVG Volume (30 Days)
472.7K
1.3M
Earning Date
05-07-2026
03-17-2026
Dividend Yield
3.36%
N/A
EPS Growth
207.80
165.16
EPS
3.18
1.01
Revenue
$3,176,718,000.00
$2,998,000.00
Revenue This Year
N/A
$1,276.65
Revenue Next Year
$7.14
$112.53
P/E Ratio
$2.25
$4.50
Revenue Growth
48.98
258.18
52 Week Low
$5.32
$3.93
52 Week High
$14.62
$7.54

Technical Indicators

Market Signals
Indicator
NUS
ABEO
Relative Strength Index (RSI) 26.17 33.98
Support Level N/A $4.00
Resistance Level $10.99 $5.62
Average True Range (ATR) 0.27 0.21
MACD 0.04 -0.06
Stochastic Oscillator 9.85 10.05

Price Performance

Historical Comparison
NUS
ABEO

About NUS Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: